Orexo develops improved pharmaceuticals addressing unmet needs, foremost within the growing space of mental illness and substance use disorders. To achieve better treatment results and increase access to care, Orexo also works with evidence-based digital therapies. The products are commercialized by Orexo in the US or via partners worldwide.